{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:50:01Z","timestamp":1790491801513,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010109","name":"Medical University of Graz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010109","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s00292-017-0298-5","type":"journal-article","created":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T06:09:36Z","timestamp":1494569376000},"page":"149-155","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Famili\u00e4res Mamma- und Ovarialkarzinom","Hereditary breast and ovarian cancer"],"prefix":"10.1007","volume":"38","author":[{"given":"S. F.","family":"Lax","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,12]]},"reference":[{"key":"298_CR1","unstructured":"Birch J, Garber J (2012) Li Fraumeni Syndrome. In Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ (Hrsg) WHO Classification of Tumours of the Breast. IARC Press, Lyon, S\u00a0183\u2013185"},{"key":"298_CR2","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","volume":"25","author":"MJ Callahan","year":"2007","unstructured":"Callahan MJ, Crum CP, Medeiros F et al (2007) Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J\u00a0Clin Oncol 25:3985\u20133990","journal-title":"J Clin Oncol"},{"key":"298_CR3","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/01.pas.0000202161.80739.ac","volume":"30","author":"ML Carcangiu","year":"2006","unstructured":"Carcangiu ML, Peissel B, Pasini B et al (2006) Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature. Am J Surg Pathol 30:1222\u20131230","journal-title":"Am J Surg Pathol"},{"key":"298_CR4","unstructured":"Chenevix-Trench G, Balleine R (2012) Ataxia teleangiectasia. In Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ (Hrsg) WHO Classification of Tumours of the Breast. IARC Press, Lyon, S\u00a0186\u2013187"},{"key":"298_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","volume":"19","author":"CP Crum","year":"2007","unstructured":"Crum CP, Drapkin R, Miron A et\u00a0al (2007) The distal fallopian tube: a\u00a0new model for pelvic serous carcinogenesis. Curr Opin Obstet Gynecol 19:3\u20139","journal-title":"Curr Opin Obstet Gynecol"},{"key":"298_CR6","first-page":"346","volume-title":"Tumours of the breast and female genital organs","author":"R Eeles","year":"2003","unstructured":"Eeles R, Piver S, Lakhani SR et\u00a0al (2003) BRCA2 syndrome. In: Tavassoli FA, Devilee P (Hrsg) Tumours of the breast and female genital organs. IARC Press, Lyon, S\u00a0346\u2013351"},{"key":"298_CR7","unstructured":"Eng C, Garber J (2012) Cowden Syndrome. In Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ (Hrsg) WHO Classification of Tumours of the Breast. IARC Press, Lyon, S\u00a0188\u2013191"},{"key":"298_CR8","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/jmedgenet-2015-103570","volume":"53","author":"JD Fackenthal","year":"2016","unstructured":"Fackenthal JD, Yoshimatsu T, Zhang B et\u00a0al (2016) Naturally occurring BRCA2 alternative mRNA splicing events in clinically relevant samples. J\u00a0Med Genet 53:548\u2013558","journal-title":"J Med Genet"},{"key":"298_CR9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/modpathol.2009.153","volume":"23","author":"K Garg","year":"2010","unstructured":"Garg K, Leitao MM Jr., Wynveen CA et\u00a0al (2010) p53 overexpression in morphologically ambiguous endometrial carcinomas correlates with adverse clinical outcomes. Mod Pathol 23:80\u201392","journal-title":"Mod Pathol"},{"key":"298_CR10","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/PAS.0b013e31826cabbd","volume":"37","author":"K Garg","year":"2013","unstructured":"Garg K, Levine DA, Olvera N et al (2013) BRCA1 immunohistochemistry in a\u00a0molecularly characterized cohort of ovarian high-grade serous carcinomas. Am J Surg Pathol 37:138\u2013146","journal-title":"Am J Surg Pathol"},{"key":"298_CR11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.gde.2010.03.001","volume":"20","author":"SA Gayther","year":"2010","unstructured":"Gayther SA, Pharoah PD (2010) The inherited genetics of ovarian and endometrial cancer. Curr Opin Genet Dev 20:231\u2013238","journal-title":"Curr Opin Genet Dev"},{"key":"298_CR12","first-page":"338","volume-title":"Tumours of the breast and female genital organs","author":"D Goldgar","year":"2003","unstructured":"Goldgar D, Eeles R, Easton D et\u00a0al (2003) BRCA1 syndrome. In: Tavassoli FA, Devilee P (Hrsg) Tumours of the breast and female genital organs. IARC Press, Lyon, S\u00a0338\u2013345"},{"key":"298_CR13","first-page":"336","volume-title":"Tumours of the breast and female genital organs","author":"D Goldgar","year":"2003","unstructured":"Goldgar D, Stratton MR (2003) Familial aggregation of cancers of the breast and female genital organs. In: Tavassoli FA, Devilee P (Hrsg) Tumours of the breast and female genital organs. IARC Press, Lyon, S\u00a0336\u2013337"},{"key":"298_CR14","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1158\/1078-0432.CCR-10-2560","volume":"17","author":"AM Gonzalez-Angulo","year":"2011","unstructured":"Gonzalez-Angulo AM, Timms KM, Liu S et al (2011) Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer. Clin Cancer Res 17:1082\u20131089","journal-title":"Clin Cancer Res"},{"key":"298_CR15","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1002\/cncr.26576","volume":"118","author":"AR Hartman","year":"2012","unstructured":"Hartman AR, Kaldate RR, Sailer LM et al (2012) Prevalence of BRCA mutations in an unselected population of triple-negative breast cancer. Cancer 118:2787\u20132795","journal-title":"Cancer"},{"key":"298_CR16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejca.2015.12.005","volume":"55","author":"J.M. Helder-Woolderink","year":"2016","unstructured":"Helder-Woolderink JM, Blok EA, Vasen HFA, Hollema H, Mourits MJ, De Bock GH (2016) Ovarian cancer in Lynch syndrome. A systematic review. Eur J Cancer 55:65\u201373","journal-title":"European Journal of Cancer"},{"key":"298_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10689-016-9916-2","volume":"16","author":"E Jarhelle","year":"2017","unstructured":"Jarhelle E, Riise Stensland HM, Maehle L et\u00a0al (2017) Characterization of BRCA1 and BRCA2 variants found in a\u00a0Norwegian breast or ovarian cancer cohort. Fam Cancer 16:1\u201316","journal-title":"Fam Cancer"},{"key":"298_CR18","volume-title":"Tumours of the female reproductive organs","year":"2014","unstructured":"Kurman RJ, Carcangiu ML, Herrington S et\u00a0al (Hrsg) (2014) Tumours of the female reproductive organs. IARC Press, Lyon"},{"key":"298_CR19","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1093\/annonc\/mdu461","volume":"25","author":"JL Meisel","year":"2014","unstructured":"Meisel JL, Hyman DM, Garg K et al (2014) The performance of BRCA1 immunohistochemistry for detecting germline, somatic, and epigenetic BRCA1 loss in high-grade serous ovarian cancer. Ann Oncol 25:2372\u20132378","journal-title":"Ann Oncol"},{"key":"298_CR20","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","volume":"2","author":"BM Norquist","year":"2016","unstructured":"Norquist BM, Harrell MI, Brady MF et\u00a0al (2016) Inherited mutations in women with ovarian carcinoma. JAMA Oncol 2:482\u2013490","journal-title":"JAMA Oncol"},{"key":"298_CR21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ygyno.2011.12.415","volume":"124","author":"KP Pennington","year":"2012","unstructured":"Pennington KP, Swisher EM (2012) Hereditary ovarian cancer: beyond the usual suspects. Gynecol Oncol 124:347\u2013353","journal-title":"Gynecol. Oncol."},{"key":"298_CR22","unstructured":"Petrucelli N, Daly MB, Pal T (1993) BRCA1- and BRCA2-associated hereditary breast and ovarian cancer. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K (Hrsg) GeneReviews(R), Seattle"},{"key":"298_CR23","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","volume":"195","author":"JM Piek","year":"2001","unstructured":"Piek JM, Van Diest PJ, Zweemer RP et\u00a0al (2001) Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J\u00a0Pathol 195:451\u2013456","journal-title":"J Pathol"},{"key":"298_CR24","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/his.12934","volume":"69","author":"Peter F Rambau","year":"2016","unstructured":"Rambau PF, Duggan MA, Ghatage P, Warfa K, Steed H, Perrier R, Kelemen LE, K\u00f6bel M (2016) Significant frequency of MSH2\/MSH6 abnormality in ovarian endometrioid carcinoma supports histotype-specific Lynch syndrome screening in ovarian carcinomas. Histopathology 69(2):288\u2013297","journal-title":"Histopathology"},{"key":"298_CR25","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","volume":"346","author":"TR Rebbeck","year":"2002","unstructured":"Rebbeck TR, Lynch HT, Neuhausen SL et\u00a0al (2002) Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N\u00a0Engl J Med 346:1616\u20131622","journal-title":"N Engl J Med"},{"key":"298_CR26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrc3181","volume":"12","author":"R Roy","year":"2012","unstructured":"Roy R, Chun J, Powell SN (2012) BRCA1 and BRCA2: different roles in a\u00a0common pathway of genome protection. Nat Rev Cancer 12:68\u201378","journal-title":"Nat Rev Cancer"},{"key":"298_CR27","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1002\/cncr.29572","volume":"121","author":"RA Sanford","year":"2015","unstructured":"Sanford RA, Song J, Gutierrez-Barrera AM et al (2015) High incidence of germline BRCA mutation in patients with ER low-positive\/PR low-positive\/HER-2 neu negative tumors. Cancer 121:3422\u20133427","journal-title":"Cancer"},{"key":"298_CR28","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/modpathol.2011.183","volume":"25","author":"RA Soslow","year":"2012","unstructured":"Soslow RA, Han G, Park KJ et\u00a0al (2012) Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma. Mod Pathol 25:625\u2013636","journal-title":"Mod Pathol"},{"key":"298_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-016-9955-8","author":"M Suryavanshi","year":"2016","unstructured":"Suryavanshi M, Kumar D, Panigrahi MK et\u00a0al (2016) Detection of false positive mutations in BRCA gene by next generation sequencing. Fam Cancer. doi:\n                        10.1007\/s10689-016-9955-8","journal-title":"Fam Cancer"},{"key":"298_CR30","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/jnci\/91.14.1241","volume":"91","author":"E Warner","year":"1999","unstructured":"Warner E, Foulkes W, Goodwin P et\u00a0al (1999) Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. J\u00a0Natl Cancer Inst 91:1241\u20131247","journal-title":"J. Natl. Cancer Inst."},{"key":"298_CR31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/01.pgp.0000101083.35393.cd","volume":"23","author":"BA Werness","year":"2004","unstructured":"Werness BA, Ramus SJ, Dicioccio RA et\u00a0al (2004) Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry. Int J Gynecol Pathol 23:29\u201334","journal-title":"Int J Gynecol Pathol"},{"key":"298_CR32","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/jmg.2010.078113","volume":"47","author":"J. R. F. Wilson","year":"2010","unstructured":"Wilson JRF, Bateman AC, Hanson H, An Q, Evans G, Rahman N, Jones JL, Eccles MD (2010) A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations. J Med Genet 47(11):771\u2013774","journal-title":"Journal of Medical Genetics"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-017-0298-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-017-0298-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-017-0298-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T18:02:12Z","timestamp":1589738532000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-017-0298-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["298"],"URL":"https:\/\/doi.org\/10.1007\/s00292-017-0298-5","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5]]}}}